Real World Impact of Remdesivir and Dexamethasone on Clinical Outcomes of Severe Coronavirus Disease 2019 in a Community Hospital.

Derek T LarsonEvan C EwersKia M GallagherAlexandra M MahoneyMadison L PaulPeter J Weina

Published in: Military medicine (2022)

We did not observe an appreciable impact on the duration of hospitalization when Remdesivir and dexamethasone were added to supportive care in a community hospital. This study was not sufficiently powered to detect the previously described mortality benefit of dexamethasone.

Keyphrases

healthcare
coronavirus disease
high dose
low dose
mental health
acute care
palliative care
adverse drug
cardiovascular events
emergency department
cardiovascular disease
coronary artery disease
chronic pain